{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T13:25:20Z","timestamp":1752672320457},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,19]]},"DOI":"10.7759\/cureus.37837","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T15:25:36Z","timestamp":1681917936000},"source":"Crossref","is-referenced-by-count":2,"title":["Rhino-Orbital Cerebral Mucormycosis: A Fatal Evolution"],"prefix":"10.7759","author":[{"given":"Said","family":"Benlamkaddem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghita","family":"Zdaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djoudline","family":"Doughmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Bennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad","family":"Chraibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Adnane","family":"Berdai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriem","family":"Abdellaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idriss","family":"Benatiya Andaloussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha","family":"Harandou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0755-4982(05)88251-X","article-title":"Mucormycosis in the diabetic patient. (Article in French)","volume":"34","author":"Chadli-Chaieb M","year":"2005","unstructured":"Chadli-Chaieb M, Bchir A, Fathallah-Mili A, Ach K, Maaroufi A, Garrouche A, Chaieb L. Mucormycosis in the diabetic patient. (Article in French). Presse Med. 2005, 34:218-22. 10.1016\/S0755-4982(05)88251-X","journal-title":"Presse Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely OA","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D, et al.. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019, 19:e405-21. 10.1016\/S1473-3099(19)30312-3","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2003.016030","article-title":"Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes","volume":"80","author":"Bhansali A","year":"2004","unstructured":"Bhansali A, Bhadada S, Sharma A, et al.. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J. 2004, 80:670-4. 10.1136\/pgmj.2003.016030","journal-title":"Postgrad Med J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation, and management","volume":"18","author":"Spellberg B","year":"2005","unstructured":"Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005, 18:556-69. 10.1128\/CMR.18.3.556-569.2005","journal-title":"Clin Microbiol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1470-9465.2004.00843.x","article-title":"Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment","volume":"10","author":"Prabhu RM","year":"2004","unstructured":"Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004, 10:31-47. 10.1111\/j.1470-9465.2004.00843.x","journal-title":"Clin Microbiol Infect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/BF02724075","article-title":"Rhino-orbital-cerebral mucormycosis in type 1 diabetes mellitus","volume":"72","author":"Bhadada S","year":"2005","unstructured":"Bhadada S, Bhansali A, Reddy KS, Bhat RV, Khandelwal N, Gupta AK. Rhino-orbital-cerebral mucormycosis in type 1 diabetes mellitus. Indian J Pediatr. 2005, 72:671-4. 10.1007\/BF02724075","journal-title":"Indian J Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01604.x","article-title":"Mucormycosis: an emerging disease?","volume":"12","author":"Bouza E","year":"2006","unstructured":"Bouza E, Mu\u00f1oz P, Guinea J. Mucormycosis: an emerging disease?. Clin Microbiol Infect. 2006, 12:7-23. 10.1111\/j.1469-0691.2006.01604.x","journal-title":"Clin Microbiol Infect"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s13546-015-1032-z","article-title":"Post-traumatic immunodepression: from pathophysiology to treatment. (Article in French)","volume":"24","author":"Roquilly A","year":"2015","unstructured":"Roquilly A, Vourc\u2019h M, Asehnoune K. Post-traumatic immunodepression: from pathophysiology to treatment. (Article in French). R\u00e9animation. 2015, 24:285-90. 10.1007\/s13546-015-1032-z","journal-title":"R\u00e9animation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2012.02.007","article-title":"Rhinocerebral mucormycosis. (Article in French)","volume":"42","author":"Lmekki S","year":"2012","unstructured":"Lmekki S, Zaki Z, El Alami MN. Rhinocerebral mucormycosis. (Article in French). Med Mal Infect. 2012, 42:171-3. 10.1016\/j.medmal.2012.02.007","journal-title":"Med Mal Infect"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(05)80041-4","article-title":"Survival factors in rhino-orbital-cerebral mucormycosis","volume":"39","author":"Yohai RA","year":"1994","unstructured":"Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol. 1994, 39:3-22. 10.1016\/S0039-6257(05)80041-4","journal-title":"Surv Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1067\/mhn.2002.126587","article-title":"Rhino-orbital and rhino-orbito-cerebral mucormycosis","volume":"127","author":"Talmi YP","year":"2002","unstructured":"Talmi YP, Goldschmied-Reouven A, Bakon M, et al.. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg. 2002, 127:22-31. 10.1067\/mhn.2002.126587","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0284185120988828","article-title":"Imaging features of rhinocerebral mucormycosis: from onset to vascular complications","volume":"63","author":"Mazzai L","year":"2022","unstructured":"Mazzai L, Anglani M, Giraudo C, Martucci M, Cester G, Causin F. Imaging features of rhinocerebral mucormycosis: from onset to vascular complications. Acta Radiol. 2022, 63:232-44. 10.1177\/0284185120988828","journal-title":"Acta Radiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg020","article-title":"In vitro susceptibilities of zygomycetes to conventional and new antifungals","volume":"51","author":"Dannaoui E","year":"2003","unstructured":"Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother. 2003, 51:45-52. 10.1093\/jac\/dkg020","journal-title":"J Antimicrob Chemother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00452-07","article-title":"In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents","volume":"51","author":"Almyroudis NG","year":"2007","unstructured":"Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother. 2007, 51:2587-90. 10.1128\/AAC.00452-07","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.3.805-810.2006","article-title":"Genetic identification of the main opportunistic Mucorales by PCR-restriction fragment length polymorphism","volume":"44","author":"Machouart M","year":"2006","unstructured":"Machouart M, Larch\u00e9 J, Burton K, et al.. Genetic identification of the main opportunistic Mucorales by PCR-restriction fragment length polymorphism. J Clin Microbiol. 2006, 44:805-10. 10.1128\/JCM.44.3.805-810.2006","journal-title":"J Clin Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.2.340-349.2006","article-title":"Molecular identification of zygomycetes from culture and experimentally infected tissues","volume":"44","author":"Schwarz P","year":"2006","unstructured":"Schwarz P, Bretagne S, Gantier JC, Garcia-Hermoso D, Lortholary O, Dromer F, Dannaoui E. Molecular identification of zygomycetes from culture and experimentally infected tissues. J Clin Microbiol. 2006, 44:340-9. 10.1128\/JCM.44.2.340-349.2006","journal-title":"J Clin Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.28920\/dhm51.1.86-93","article-title":"Hyperbaric oxygen treatment: results in seven patients with severe bacterial postoperative central nervous system infections and refractory mucormycosis","volume":"51","author":"Valente Aguiar P","year":"2021","unstructured":"Valente Aguiar P, Carvalho B, Monteiro P, Linhares P, Camacho \u00d3, Vaz R. Hyperbaric oxygen treatment: results in seven patients with severe bacterial postoperative central nervous system infections and refractory mucormycosis. Diving Hyperb Med. 2021, 51:86-93. 10.28920\/dhm51.1.86-93","journal-title":"Diving Hyperb Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12663-022-01810-6","article-title":"Functional endoscopic sinus surgery and recurrence of post-COVID mucormycosis","author":"Rudagi BM","year":"2022","unstructured":"Rudagi BM, Goyal J, Palande C, Patil P. Functional endoscopic sinus surgery and recurrence of post-COVID mucormycosis. J Maxillofac Oral Surg. 2022, 1-8. 10.1007\/s12663-022-01810-6","journal-title":"J Maxillofac Oral Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002256","article-title":"Retrobulbar injection of amphotericin B in patients with COVID-19 associated orbital mucormycosis: a systematic review","volume":"38","author":"Sharifi A","year":"2022","unstructured":"Sharifi A, Akbari Z, Shafie'ei M, Nasiri N, Sharifi M, Shafiei M, Zand A. Retrobulbar injection of amphotericin B in patients with COVID-19 associated orbital mucormycosis: a systematic review. Ophthalmic Plast Reconstr Surg. 2022, 38:425-32. 10.1097\/IOP.0000000000002256","journal-title":"Ophthalmic Plast Reconstr Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/149889-rhino-orbital-cerebral-mucormycosis-a-fatal-evolution","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:15Z","timestamp":1707508815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/149889-rhino-orbital-cerebral-mucormycosis-a-fatal-evolution"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.37837","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,19]]}}}